Prevention and treatment of osteoporosis in prostate cancer Recommendations

BACKGROUND: The efficacy and safety of capecitabine and bevacizumab in elderly patients with metastatic colorectal cancer (mCRC) considered unsuitable for receiving

The multicase- control study in Spain (MCC- Spain) includes three prospective cohorts of patients with cancer (colorectal, female breast and prostate) with the aim to

Among inflammatory cells, neutrophils are particularly important for tumor initiation: ligands for CXRC2 (a receptor with highest expression on neutrophils) are abundant in early

It is thought that a defective or missing BRCA1 protein is unable to repair damaged DNA or fix mutations that occur in other genes, which is the main cause of its association

Morphofunctional and Molecular Assessment of Nutritional Status in Head and Neck Cancer Patients Undergoing Systemic Treatment: Role of Inflammasome in Clinical Nutrition..

Thus, GOAT might represent a valuable novel biomarker for prostate cancer, alone or in combination with other biomarkers (e.g. PSA, PCA3), to improve prostate


On the other hand, because in the last years exosomes are being studied intensively in body fluids as a source of new diagnostic biomarkers, but there was still no studies

Aim: Our objective was to determine changes in bone mineral density (BMD), trabecular bone score (TBS), and body composition after 2 years of therapy with recombinant